Cowen and Company’s Tristar Acquisition I Corp. Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share TRIS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-360,332
Closed -$43.2K 763
2024
Q2
$43.2K Buy
360,332
+181,503
+101% +$22.4K ﹤0.01% 331
2024
Q1
$12.4K Buy
178,829
+19,700
+12% +$762 ﹤0.01% 489
2023
Q4
$3.75K Buy
+159,129
New +$4.49K ﹤0.01% 487

Cowen and Company's TRIS.WS Position: Q3 2024 in Review

Cowen and Company sold out of Tristar Acquisition I Corp. Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (TRIS.WS) in Q3 2024, closing a stake of 360,332 shares — an estimated $43.2K sold.

Cowen and Company first reported a position in TRIS.WS in Q4 2023 and held it in 3 quarters. The position peaked at $43.2K in Q2 2024. 0 funds tracked by Wall St. Rank hold TRIS.WS as of Q3 2024.

  • Cowen and Company reported no remaining Tristar Acquisition I Corp. Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position as of Q3 2024 after selling out during the quarter.
  • Cowen and Company sold 360,332 Tristar Acquisition I Corp. Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share shares in Q3 2024, an estimated $43.2K.
  • Cowen and Company first reported a position in Tristar Acquisition I Corp. Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share in Q4 2023 and held it in 3 quarters.
  • Cowen and Company's Tristar Acquisition I Corp. Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position peaked at $43.2K in Q2 2024.
  • 0 funds tracked by Wall St. Rank held Tristar Acquisition I Corp. Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share as of Q3 2024.

Based on Cowen and Company's 13F filing for Q3 2024, filed 12 Nov 2024.